Human trials for a potentially innovative HIV medication that has been heralded as a possible “cure” for the infection are ready to begin.

The American Food and Drug Administration (FDA) has cleared the treatment’s advancement to Phase I/II human trials, according to a press statement from Excision Biotherapeutics, a biotech firm.

EBT-101, Excision’s possible treatment, is being researched in collaboration with Temple University researchers in Philadelphia.

“If you only make a single cut, the virus may adapt around it,” Excision CEO Daniel Dornbusch told Fierce Biotech. To disable the viral DNA, we make numerous incisions.”

What do you think about this as a reader? What is your take on this matter? Would you say that this is indeed great?

Do not forget to follow me for more stories and visit my page to read also on the ones that you might have missed already.